Related by context. Frequent words. (Click for all words.) 84 Marketing Authorization Application 75 Biologics License Application BLA 72 New Drug Application 71 Biologics License Application 70 Marketing Authorization 68 sNDA 68 sBLA 64 Rhucin 64 European Medicines Evaluation 63 Phase III pivotal 63 NDA submission 63 Ceplene 62 Phase III clinical 62 Investigational Device Exemption IDE 62 Loramyc ® 62 Complete Response letter 62 pivotal Phase III 61 Orphan Drug designation 61 Renvela 61 Phase III clinical trials 61 ATryn R 61 Phase IIa trial 61 Ceftobiprole 60 Fast Track designation 60 Orphan Drug Designation 60 methylnaltrexone 60 BENLYSTA 59 Synvisc One 59 cutaneous T cell 59 FOSRENOL 59 Ceplene R 59 Phase III Trial 59 Cladribine Tablets 59 Approvable Letter 59 Torisel 59 Satraplatin 59 Qutenza 59 Dyloject 59 Fast Track Designation 59 Cimzia ® 59 ecallantide 59 alogliptin 59 Phase 2b clinical 59 Ventavis 58 Neupro ® 58 intravenous formulation 58 LIALDA 58 oritavancin 58 Drug Application 58 confirmatory Phase 3 58 Phase 2a clinical 58 Phase IIb clinical 58 INDs 58 Investigational 57 European Medicines Agency 57 Phase IIb trial 57 Rifaximin 57 Bronchitol 57 CHMP 57 L MTP PE 57 Topical Interferon Alpha 2b 57 Oracea 57 injectable formulation 57 pivotal Phase 57 StaphVAX 57 Esbriet 57 Complete Response Letter 57 satraplatin 57 SEROQUEL XR 56 Zerenex 56 Pennsaid 56 phase IIb 56 Exalgo 56 daily tramadol 56 Vasovist 56 alitretinoin 56 Phase IIa 56 New Drug IND 56 Ceplene ® 56 eltrombopag 56 Horizant 56 Flutiform 56 Phase 2b study 56 ADVEXIN 56 SILENOR TM 56 ONSOLIS 56 velaglucerase alfa 56 Phase III trials 55 phase IIa 55 TORISEL 55 investigational compound 55 PROMACTA 55 Aclasta 55 Entereg 55 Marqibo 55 Phase Ib 55 Antegren 55 relapsed multiple myeloma 55 PDUFA date 55 clofarabine 55 opioid induced constipation